Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant 1
Synonyms:
NACP; PARK1; PARK4; PD1
Immunogen
The antiserum was produced against synthesized non-phosphopeptide derived from human Synuclein around the phosphorylation site of serine 129 (M-P-SP-E-E).
Buffer
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clone Name
Isotype
IgG
Species Reactivity
Human, Mouse
Concentration
1mg/ml
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. (Protein A or G Sepharose)
Guaranteed Application *
WB, IHC
Suggested Dilutions
WB: 1:500~1:3000, IHC: 1:50~1:100, ELISA: 1:1000
Background
Synuclein (Ab-129) antibody detects endogenous levels of total Synuclein protein.
Related Pathway
EGFR1 Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using Synuclein (Ab-129) antibody.The picture on the right is treated with the synthesized peptide.
Researchers who bought this antibody have also purchased:
